| Family Wellness Chiropractic Pc | |
|
1809 Commons Cir, A, Yukon, OK 73099 | |
| (405) 577-6268 | |
| (405) 577-6371 |
| Full Name | Family Wellness Chiropractic Pc |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 1809 Commons Cir, Yukon, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154503639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 3850 (Oklahoma) | Primary |
| Provider Name | Christopher T Park |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1902981376 PECOS PAC ID: 6103803622 Enrollment ID: I20040702000154 |
News Archive
National and international organizations are ill-prepared to exploit e-health systems in the event of the emergence of a major pandemic disease, according to a research paper to be published in the International Journal of Biomedical Engineering and Technology.
A pair of brain-imaging studies suggest researchers may be able to predict how likely young adults are to develop problem drinking or engage in risky sexual behavior in response to stress.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
Taking a critical step toward the development of a multifunctional nanoscale anticancer agent that can detect cancer, treat it, and then report on the success or failure of that treatment, investigators at the University of Michigan have developed a nanoscale sensor of cell death.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
| Provider Name | Amanda Miller |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1275712184 PECOS PAC ID: 4385715028 Enrollment ID: I20080624000202 |
News Archive
National and international organizations are ill-prepared to exploit e-health systems in the event of the emergence of a major pandemic disease, according to a research paper to be published in the International Journal of Biomedical Engineering and Technology.
A pair of brain-imaging studies suggest researchers may be able to predict how likely young adults are to develop problem drinking or engage in risky sexual behavior in response to stress.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
Taking a critical step toward the development of a multifunctional nanoscale anticancer agent that can detect cancer, treat it, and then report on the success or failure of that treatment, investigators at the University of Michigan have developed a nanoscale sensor of cell death.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
| Provider Name | Teresa A Vestal |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1558693614 PECOS PAC ID: 7315103132 Enrollment ID: I20120724000243 |
News Archive
National and international organizations are ill-prepared to exploit e-health systems in the event of the emergence of a major pandemic disease, according to a research paper to be published in the International Journal of Biomedical Engineering and Technology.
A pair of brain-imaging studies suggest researchers may be able to predict how likely young adults are to develop problem drinking or engage in risky sexual behavior in response to stress.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
Taking a critical step toward the development of a multifunctional nanoscale anticancer agent that can detect cancer, treat it, and then report on the success or failure of that treatment, investigators at the University of Michigan have developed a nanoscale sensor of cell death.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
| Provider Name | Jonathan Ray Vestal |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1508299116 PECOS PAC ID: 0547497836 Enrollment ID: I20131211001823 |
News Archive
National and international organizations are ill-prepared to exploit e-health systems in the event of the emergence of a major pandemic disease, according to a research paper to be published in the International Journal of Biomedical Engineering and Technology.
A pair of brain-imaging studies suggest researchers may be able to predict how likely young adults are to develop problem drinking or engage in risky sexual behavior in response to stress.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
Taking a critical step toward the development of a multifunctional nanoscale anticancer agent that can detect cancer, treat it, and then report on the success or failure of that treatment, investigators at the University of Michigan have developed a nanoscale sensor of cell death.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
| Provider Name | Leah Bagg |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1457043952 PECOS PAC ID: 8123489580 Enrollment ID: I20230801003160 |
News Archive
National and international organizations are ill-prepared to exploit e-health systems in the event of the emergence of a major pandemic disease, according to a research paper to be published in the International Journal of Biomedical Engineering and Technology.
A pair of brain-imaging studies suggest researchers may be able to predict how likely young adults are to develop problem drinking or engage in risky sexual behavior in response to stress.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
Taking a critical step toward the development of a multifunctional nanoscale anticancer agent that can detect cancer, treat it, and then report on the success or failure of that treatment, investigators at the University of Michigan have developed a nanoscale sensor of cell death.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Family Wellness Chiropractic Pc 1809 Commons Cir, A, Yukon, OK 73099 Ph: (405) 577-6268 | Family Wellness Chiropractic Pc 1809 Commons Cir, A, Yukon, OK 73099 Ph: (405) 577-6268 |
News Archive
National and international organizations are ill-prepared to exploit e-health systems in the event of the emergence of a major pandemic disease, according to a research paper to be published in the International Journal of Biomedical Engineering and Technology.
A pair of brain-imaging studies suggest researchers may be able to predict how likely young adults are to develop problem drinking or engage in risky sexual behavior in response to stress.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
Taking a critical step toward the development of a multifunctional nanoscale anticancer agent that can detect cancer, treat it, and then report on the success or failure of that treatment, investigators at the University of Michigan have developed a nanoscale sensor of cell death.
A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group.
› Verified 8 days ago
Dr. Matthew Unruh, Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1321 Chimney Hill Rd, Yukon, OK 73099 Phone: 405-823-1814 | |
Dr. Orville Lee Rau, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 324 Elm Ave, Yukon, OK 73099 Phone: 405-354-5231 Fax: 405-354-2371 | |
Addison Munsch, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 1050 W Vandament Ave, Yukon, OK 73099 Phone: 405-354-5753 | |
Mr. Mark A. Kimble Jr., D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 11301 W. Reno, Suite G., Yukon, OK 73099 Phone: 405-265-3920 Fax: 405-265-3922 | |
Christian Minard, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 12110 Ashford Dr Ste 200, Yukon, OK 73099 Phone: 405-883-6200 | |
Dr. Christina M Redding, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1117 S Ranchwood Blvd, Yukon, OK 73099 Phone: 405-577-6100 Fax: 405-494-7313 | |
Redding Family Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1117 S Ranchwood Blvd, Yukon, OK 73099 Phone: 405-577-6100 Fax: 405-494-7313 |